National Cancer Institute. SEER cancer statistics fact sheets: bone and joint cancer. Accessed July 10, 2024. Available at: https://seer.cancer.gov/statfacts/html/bones.html

• PubMed
National Cancer Institute. SEER cancer statistics fact sheets: bone and joint cancer. Accessed July 10, 2024. Available at: https://seer.cancer.gov/statfacts/html/bones.html)| false
• Search Google Scholar
• Export Citation

Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA Cancer J Clin 2025;75:10–45.

• PubMed
Siegel RL, Kratzer TB, Giaquinto AN, Cancer statistics, 2025. CA Cancer J Clin 2025;75:10–45.)| false
• Search Google Scholar
• Export Citation

MD Anderson Cancer Center. Bone cancer. Accessed January 16, 2025. Available at: https://www.mdanderson.org/cancer-types/bone-cancer.html#:∼:text=In%20the%20United%20States%2C%20more,all% 20cancers%20in%20this%20country

• PubMed
MD Anderson Cancer Center. Bone cancer. Accessed January 16, 2025. Available at: https://www.mdanderson.org/cancer-types/bone-cancer.html#:∼:text=In%20the%20United%20States%2C%20more,all% 20cancers%20in%20this%20country)| false
• Search Google Scholar
• Export Citation

National Cancer Institute. Primary bone cancer. Accessed January 16, 2025. Available at: https://www.cancer.gov/types/bone/bone-fact-sheet

• PubMed
National Cancer Institute. Primary bone cancer. Accessed January 16, 2025. Available at: https://www.cancer.gov/types/bone/bone-fact-sheet)| false
• Search Google Scholar
• Export Citation

WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Soft Tissue and Bone Tumours, 5th ed. IARC Press; 2020.

• PubMed
WHO Classification of Tumours Editorial Board. WHO Classification of Tumours: Soft Tissue and Bone Tumours, 5th ed. IARC Press; 2020.)| false
• Export Citation

Limaiem F, Davis DD, Sticco KL. Chondrosarcoma. Accessed January 16, 2025. Available at: https://www.ncbi.nlm.nih.gov/books/NBK538132/

• PubMed
Limaiem F, Davis DD, Sticco KL. Chondrosarcoma. Accessed January 16, 2025. Available at: https://www.ncbi.nlm.nih.gov/books/NBK538132/)| false
• Search Google Scholar
• Export Citation

McMaster ML, Goldstein AM, Bromley CM, et al. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 2001;12:1–11.

• PubMed
McMaster ML, Goldstein AM, Bromley CM, Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 2001;12:1–11.)| false
• Search Google Scholar
• Export Citation

Walcott BP, Nahed BV, Mohyeldin A, et al. Chordoma: current concepts, management, and future directions. Lancet Oncol 2012;13:e69–76.

• PubMed
Walcott BP, Nahed BV, Mohyeldin A, Chordoma: current concepts, management, and future directions. Lancet Oncol 2012;13:e69–76.)| false
• Search Google Scholar
• Export Citation

Wedekind MF, Widemann BC, Cote G. Chordoma: Current status, problems, and future directions. Curr Probl Cancer 2021;45:100771.

• PubMed
Wedekind MF, Widemann BC, Cote G. Chordoma: Current status, problems, and future directions. Curr Probl Cancer 2021;45:100771.)| false
• Search Google Scholar
• Export Citation

de Alava E, Gerald WL. Molecular biology of the Ewing’s sarcoma/ primitive neuroectodermal tumor family. J Clin Oncol 2000;18:204–213.

• PubMed
de Alava E, Gerald WL. Molecular biology of the Ewing’s sarcoma/ primitive neuroectodermal tumor family. J Clin Oncol 2000;18:204–213.)| false
• Search Google Scholar
• Export Citation

Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors–a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294–299.

• PubMed
Delattre O, Zucman J, Melot T, The Ewing family of tumors–a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294–299.)| false
• Search Google Scholar
• Export Citation

Denny CT. Gene rearrangements in Ewing’s sarcoma. Cancer Invest 1996;14:83–88.

• PubMed
Denny CT. Gene rearrangements in Ewing’s sarcoma. Cancer Invest 1996;14:83–88.)| false
• Search Google Scholar
• Export Citation

Burchill SA. Molecular abnormalities in Ewing’s sarcoma. Expert Rev Anticancer Ther 2008;8:1675–1687.

• PubMed
Burchill SA. Molecular abnormalities in Ewing’s sarcoma. Expert Rev Anticancer Ther 2008;8:1675–1687.)| false
• Search Google Scholar
• Export Citation

Apfelbaum AA, Wrenn ED, Lawlor ER. The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: a review. Front Oncol 2022;12:1044707.

• PubMed
Apfelbaum AA, Wrenn ED, Lawlor ER. The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: a review. Front Oncol 2022;12:1044707.)| false
• Search Google Scholar
• Export Citation

Mirabello L, Zhu B, Koster R, et al. Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma. JAMA Oncol 2020;6:724–734.

• PubMed
Mirabello L, Zhu B, Koster R, Frequency of pathogenic germline variants in cancer-susceptibility genes in patients with osteosarcoma. JAMA Oncol 2020;6:724–734.)| false
• Search Google Scholar
• Export Citation

Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233–1238.

• PubMed
Malkin D, Li FP, Strong LC, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233–1238.)| false
• Search Google Scholar
• Export Citation

McIntyre JF, Smith-Sorensen B, Friend SH, et al. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 1994;12:925–930.

• PubMed
McIntyre JF, Smith-Sorensen B, Friend SH, Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 1994;12:925–930.)| false
• Search Google Scholar
• Export Citation

Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer 2012;118:1387–1396.

• PubMed
Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer 2012;118:1387–1396.)| false
• Search Google Scholar
• Export Citation

Ottaviani G, Jaffe N. The etiology of osteosarcoma. Cancer Treat Res 2009;152:15–32.

• PubMed
Ottaviani G, Jaffe N. The etiology of osteosarcoma. Cancer Treat Res 2009;152:15–32.)| false
• Search Google Scholar
• Export Citation

MacCarthy A, Bayne AM, Draper GJ, et al. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol 2009;93:1159–1162.

• PubMed
MacCarthy A, Bayne AM, Draper GJ, Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol 2009;93:1159–1162.)| false
• Search Google Scholar
• Export Citation

Calvert GT, Randall RL, Jones KB, et al. At-risk populations for osteosarcoma: the syndromes and beyond. Sarcoma 2012;2012:152382.

• PubMed
Calvert GT, Randall RL, Jones KB, At-risk populations for osteosarcoma: the syndromes and beyond. Sarcoma 2012;2012:152382.)| false
• Search Google Scholar
• Export Citation

Kalra S, Grimer RJ, Spooner D, et al. Radiation-induced sarcomas of bone: factors that affect outcome. J Bone Joint Surg Br 2007;89:808–813.

• PubMed
Kalra S, Grimer RJ, Spooner D, Radiation-induced sarcomas of bone: factors that affect outcome. J Bone Joint Surg Br 2007;89:808–813.)| false
• Search Google Scholar
• Export Citation

Mavrogenis AF, Pala E, Guerra G, Ruggieri P. Post-radiation sarcomas. Clinical outcome of 52 Patients. J Surg Oncol 2012;105:570–576.

• PubMed
Mavrogenis AF, Pala E, Guerra G, Ruggieri P. Post-radiation sarcomas. Clinical outcome of 52 Patients. J Surg Oncol 2012;105:570–576.)| false
• Search Google Scholar
• Export Citation

Bernstein M, Kovar H, Paulussen M, et al. Ewing’s sarcoma family of tumors: current management. Oncologist 2006;11:503–519.

• PubMed
Bernstein M, Kovar H, Paulussen M, Ewing’s sarcoma family of tumors: current management. Oncologist 2006;11:503–519.)| false
• Search Google Scholar
• Export Citation

Subbiah V, Anderson P, Lazar AJ, et al. Ewing’s sarcoma: standard and experimental treatment options. Curr Treat Options Oncol 2009;10:126–140.

• PubMed
Subbiah V, Anderson P, Lazar AJ, Ewing’s sarcoma: standard and experimental treatment options. Curr Treat Options Oncol 2009;10:126–140.)| false
• Search Google Scholar
• Export Citation

Rathore R, Van Tine BA. Pathogenesis and current treatment of osteosarcoma: perspectives for future therapies. J Clin Med 2021;10:1182.

• PubMed
Rathore R, Van Tine BA. Pathogenesis and current treatment of osteosarcoma: perspectives for future therapies. J Clin Med 2021;10:1182.)| false
• Search Google Scholar
• Export Citation

Federman N, Bernthal N, Eilber FC, Tap WD. The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol 2009;10:82–93.

• PubMed
Federman N, Bernthal N, Eilber FC, Tap WD. The multidisciplinary management of osteosarcoma. Curr Treat Options Oncol 2009;10:82–93.)| false
• Search Google Scholar
• Export Citation

Xu M, Wang Z, Yu XC, et al. Guideline for limb-salvage treatment of osteosarcoma. Orthop Surg 2020;12:1021–1029.

• PubMed
Xu M, Wang Z, Yu XC, Guideline for limb-salvage treatment of osteosarcoma. Orthop Surg 2020;12:1021–1029.)| false
• Search Google Scholar
• Export Citation

American Cancer Society. Early detection, diagnosis, and staging of Ewing tumors. Accessed July 18, 2024. Available at: https://www.cancer.org/content/dam/CRC/PDF/Public/8621.00.pdf

• PubMed
American Cancer Society. Early detection, diagnosis, and staging of Ewing tumors. Accessed July 18, 2024. Available at: https://www.cancer.org/content/dam/CRC/PDF/Public/8621.00.pdf)| false
• Search Google Scholar
• Export Citation

Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol 2000;18:3108–3114.

• PubMed
Cotterill SJ, Ahrens S, Paulussen M, Prognostic factors in Ewing’s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing’s Sarcoma Study Group. J Clin Oncol 2000;18:3108–3114.)| false
• Search Google Scholar
• Export Citation

Kager L, Zoubek A, Potschger U, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003;21:2011–2018.

• PubMed
Kager L, Zoubek A, Potschger U, Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003;21:2011–2018.)| false
• Search Google Scholar
• Export Citation

Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual, 8th ed. New York, NY: Springer; 2017.

• PubMed
Amin MB, Edge SB, Greene FL, AJCC Cancer Staging Manual, 8th ed. New York, NY: Springer; 2017.)| false
• Search Google Scholar
• Export Citation

Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917–2931.

• PubMed
Lee SJ, Schover LR, Partridge AH, American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917–2931.)| false
• Search Google Scholar
• Export Citation

Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am 1993;75:1276–1281.

• PubMed
Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am 1993;75:1276–1281.)| false
• Search Google Scholar
• Export Citation

Schuetze SM. Utility of positron emission tomography in sarcomas. Curr Opin Oncol 2006;18:369–373.

• PubMed
Schuetze SM. Utility of positron emission tomography in sarcomas. Curr Opin Oncol 2006;18:369–373.)| false
• Search Google Scholar
• Export Citation

Volker T, Denecke T, Steffen I, et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 2007;25:5435–5441.

• PubMed
Volker T, Denecke T, Steffen I, Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 2007;25:5435–5441.)| false
• Search Google Scholar
• Export Citation

Heck RK, Peabody TD, Simon MA. Staging of primary malignancies of bone. CA Cancer J Clin 2006;56:366–375.

• PubMed
Heck RK, Peabody TD, Simon MA. Staging of primary malignancies of bone. CA Cancer J Clin 2006;56:366–375.)| false
• Search Google Scholar
• Export Citation

Chambers M, O’Hern K, Kerr DA. Fine-needle aspiration biopsy for the diagnosis of bone and soft tissue lesions: a systematic review and meta-analysis. J Am Soc Cytopathol 2020;9:429–441.

• PubMed
Chambers M, O’Hern K, Kerr DA. Fine-needle aspiration biopsy for the diagnosis of bone and soft tissue lesions: a systematic review and meta-analysis. J Am Soc Cytopathol 2020;9:429–441.)| false
• Search Google Scholar
• Export Citation

Dirks M, Ewerbeck NK, Ballhause TM, et al. The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system. World J Surg Oncol 2023;21:4.

• PubMed
Dirks M, Ewerbeck NK, Ballhause TM, The diagnostic accuracy of 332 incisional biopsies in patients with malignant tumors in the musculoskeletal system. World J Surg Oncol 2023;21:4.)| false
• Search Google Scholar
• Export Citation

Ashford RU, McCarthy SW, Scolyer RA, et al. Surgical biopsy with intra-operative frozen section. An accurate and cost-effective method for diagnosis of musculoskeletal sarcomas. J Bone Joint Surg Br 2006;88:1207–1211.

• PubMed
Ashford RU, McCarthy SW, Scolyer RA, Surgical biopsy with intra-operative frozen section. An accurate and cost-effective method for diagnosis of musculoskeletal sarcomas. J Bone Joint Surg Br 2006;88:1207–1211.)| false
• Search Google Scholar
• Export Citation

Skrzynski MC, Biermann JS, Montag A, Simon MA. Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors. J Bone Joint Surg Am 1996;78:644–649.

• PubMed
Skrzynski MC, Biermann JS, Montag A, Simon MA. Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors. J Bone Joint Surg Am 1996;78:644–649.)| false
• Search Google Scholar
• Export Citation

Welker JA, Henshaw RM, Jelinek J, et al. The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer 2000;89:2677–2686.

• PubMed
Welker JA, Henshaw RM, Jelinek J, The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Cancer 2000;89:2677–2686.)| false
• Search Google Scholar
• Export Citation

Mitsuyoshi G, Naito N, Kawai A, et al. Accurate diagnosis of musculoskeletal lesions by core needle biopsy. J Surg Oncol 2006;94:21–27.

• PubMed
Mitsuyoshi G, Naito N, Kawai A, Accurate diagnosis of musculoskeletal lesions by core needle biopsy. J Surg Oncol 2006;94:21–27.)| false
• Search Google Scholar
• Export Citation

Adams SC, Potter BK, Pitcher DJ, Temple HT. Office-based core needle biopsy of bone and soft tissue malignancies: an accurate alternative to open biopsy with infrequent complications. Clin Orthop Relat Res 2010;468:2774–2780.

• PubMed
Adams SC, Potter BK, Pitcher DJ, Temple HT. Office-based core needle biopsy of bone and soft tissue malignancies: an accurate alternative to open biopsy with infrequent complications. Clin Orthop Relat Res 2010;468:2774–2780.)| false
• Search Google Scholar
• Export Citation

Rimondi E, Rossi G, Bartalena T, et al. Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2027 cases. Eur J Radiol 2011;77:34–42.

• PubMed
Rimondi E, Rossi G, Bartalena T, Percutaneous CT-guided biopsy of the musculoskeletal system: results of 2027 cases. Eur J Radiol 2011;77:34–42.)| false
• Search Google Scholar
• Export Citation

Gogna A, Peh WC, Munk PL. Image-guided musculoskeletal biopsy. Radiol Clin North Am 2008;46:455–473.

• PubMed
Gogna A, Peh WC, Munk PL. Image-guided musculoskeletal biopsy. Radiol Clin North Am 2008;46:455–473.)| false
• Search Google Scholar
• Export Citation

Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 1996;78:656–663.

• PubMed
Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am 1996;78:656–663.)| false
• Search Google Scholar
• Export Citation

Liu PT, Valadez SD, Chivers FS, et al. Anatomically based guidelines for core needle biopsy of bone tumors: implications for limb-sparing surgery. Radiographics 2007;27:189–205.

• PubMed
Liu PT, Valadez SD, Chivers FS, Anatomically based guidelines for core needle biopsy of bone tumors: implications for limb-sparing surgery. Radiographics 2007;27:189–205.)| false
• Search Google Scholar
• Export Citation

Huang AJ, Kattapuram SV. Musculoskeletal neoplasms: biopsy and intervention. Radiol Clin North Am 2011;49:1287–1305.

• PubMed
Huang AJ, Kattapuram SV. Musculoskeletal neoplasms: biopsy and intervention. Radiol Clin North Am 2011;49:1287–1305.)| false
• Search Google Scholar
• Export Citation

Davies NM, Livesley PJ, Cannon SR. Recurrence of an osteosarcoma in a needle biopsy track. J Bone Joint Surg Br 1993;75:977–978.

• PubMed
Davies NM, Livesley PJ, Cannon SR. Recurrence of an osteosarcoma in a needle biopsy track. J Bone Joint Surg Br 1993;75:977–978.)| false
• Search Google Scholar
• Export Citation

Saghieh S, Masrouha KZ, Musallam KM, et al. The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J 2010;30:80–83.

• PubMed
Saghieh S, Masrouha KZ, Musallam KM, The risk of local recurrence along the core-needle biopsy tract in patients with bone sarcomas. Iowa Orthop J 2010;30:80–83.)| false
• Search Google Scholar
• Export Citation

Seeger LL. Revisiting tract seeding and compartmental anatomy for percutaneous image-guided musculoskeletal biopsies. Skeletal Radiol 2019;48:499–501.

• PubMed
Seeger LL. Revisiting tract seeding and compartmental anatomy for percutaneous image-guided musculoskeletal biopsies. Skeletal Radiol 2019;48:499–501.)| false
• Search Google Scholar
• Export Citation

Yang YJ, Damron TA. Comparison of needle core biopsy and fine- needle aspiration for diagnostic accuracy in musculoskeletal lesions. Arch Pathol Lab Med 2004;128:759–764.

• PubMed
Yang YJ, Damron TA. Comparison of needle core biopsy and fine- needle aspiration for diagnostic accuracy in musculoskeletal lesions. Arch Pathol Lab Med 2004;128:759–764.)| false
• Search Google Scholar
• Export Citation

Patel S, DeLaney TF. Advanced-technology radiation therapy for bone sarcomas. Cancer Control 2008;15:21–37.

• PubMed
Patel S, DeLaney TF. Advanced-technology radiation therapy for bone sarcomas. Cancer Control 2008;15:21–37.)| false
• Search Google Scholar
• Export Citation

McGovern SL, Mahajan A. Progress in radiotherapy for pediatric sarcomas. Curr Oncol Rep 2012;14:320–326.

• PubMed
McGovern SL, Mahajan A. Progress in radiotherapy for pediatric sarcomas. Curr Oncol Rep 2012;14:320–326.)| false
• Search Google Scholar
• Export Citation

Shing DC, McMullan DJ, Roberts P, et al. FUS/ERG gene fusions in Ewing’s tumors. Cancer Res 2003;63:4568–4576.

• PubMed
Shing DC, McMullan DJ, Roberts P, FUS/ERG gene fusions in Ewing’s tumors. Cancer Res 2003;63:4568–4576.)| false
• Search Google Scholar
• Export Citation

Ng TL, O’Sullivan MJ, Pallen CJ, et al. Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 2007;9:459–463.

• PubMed
Ng TL, O’Sullivan MJ, Pallen CJ, Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 2007;9:459–463.)| false
• Search Google Scholar
• Export Citation

Ambros IM, Ambros PF, Strehl S, et al. MIC2 is a specific marker for Ewing’s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing’s sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991;67:1886–1893.

• PubMed
Ambros IM, Ambros PF, Strehl S, MIC2 is a specific marker for Ewing’s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing’s sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991;67:1886–1893.)| false
• Search Google Scholar
• Export Citation

Perlman EJ, Dickman PS, Askin FB, et al. Ewing’s sarcoma–routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. Hum Pathol 1994;25:304–307.

• PubMed
Perlman EJ, Dickman PS, Askin FB, Ewing’s sarcoma–routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. Hum Pathol 1994;25:304–307.)| false
• Search Google Scholar
• Export Citation

Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol 2006;19:659–668.

• PubMed
Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol 2006;19:659–668.)| false
• Search Google Scholar
• Export Citation

Machado I, Navarro S, Llombart-Bosch A. Ewing sarcoma and the new emerging Ewing-like sarcomas: (CIC and BCOR-rearranged-sarcomas). A systematic review. Histol Histopathol 2016;31:1169–1181.

• PubMed
Machado I, Navarro S, Llombart-Bosch A. Ewing sarcoma and the new emerging Ewing-like sarcomas: (CIC and BCOR-rearranged-sarcomas). A systematic review. Histol Histopathol 2016;31:1169–1181.)| false
• Search Google Scholar
• Export Citation

Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP. Ewing sarcoma and Ewing-like tumors. Virchows Arch 2020;476:109–119.

• PubMed
Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP. Ewing sarcoma and Ewing-like tumors. Virchows Arch 2020;476:109–119.)| false
• Search Google Scholar
• Export Citation

Riggi N, Suva ML, Stamenkovic I. Ewing’s Sarcoma. N Engl J Med 2021;384:154–164.

• PubMed
Riggi N, Suva ML, Stamenkovic I. Ewing’s Sarcoma. N Engl J Med 2021;384:154–164.)| false
• Search Google Scholar
• Export Citation

Glaubiger DL, Makuch R, Schwarz J, et al. Determination of prognostic factors and their influence on therapeutic results in patients with Ewing’s sarcoma. Cancer 1980;45:2213–2219.

• PubMed
Glaubiger DL, Makuch R, Schwarz J, Determination of prognostic factors and their influence on therapeutic results in patients with Ewing’s sarcoma. Cancer 1980;45:2213–2219.)| false
• Search Google Scholar
• Export Citation

Gobel V, Jurgens H, Etspuler G, et al. Prognostic significance of tumor volume in localized Ewing’s sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987;113:187–191.

• PubMed
Gobel V, Jurgens H, Etspuler G, Prognostic significance of tumor volume in localized Ewing’s sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987;113:187–191.)| false
• Search Google Scholar
• Export Citation

Ahrens S, Hoffmann C, Jabar S, et al. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study. Med Pediatr Oncol 1999;32:186–195.

• PubMed
Ahrens S, Hoffmann C, Jabar S, Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study. Med Pediatr Oncol 1999;32:186–195.)| false
• Search Google Scholar
• Export Citation

Bacci G, Longhi A, Ferrari S, et al. Prognostic factors in non-metastatic Ewing’s sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol 2006;45:469–475.

• PubMed
Bacci G, Longhi A, Ferrari S, Prognostic factors in non-metastatic Ewing’s sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998. Acta Oncol 2006;45:469–475.)| false
• Search Google Scholar
• Export Citation

Rodríguez-Galindo C, Liu T, Krasin MJ, et al. Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children’s Research Hospital studies. Cancer 2007;110:375–384.

• PubMed
Rodríguez-Galindo C, Liu T, Krasin MJ, Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children’s Research Hospital studies. Cancer 2007;110:375–384.)| false
• Search Google Scholar
• Export Citation

Serlo J, Helenius I, Vettenranta K, et al. Surgically treated patients with axial and peripheral Ewing’s sarcoma family of tumours: a population based study in Finland during 1990–2009. Eur J Surg Oncol 2015;41:893–898.

• PubMed
Serlo J, Helenius I, Vettenranta K, Surgically treated patients with axial and peripheral Ewing’s sarcoma family of tumours: a population based study in Finland during 1990–2009. Eur J Surg Oncol 2015;41:893–898.)| false
• Search Google Scholar
• Export Citation

Grevener K, Haveman LM, Ranft A, et al. Management and outcome of Ewing sarcoma of the head and neck. Pediatr Blood Cancer 2016;63:604–610.

• PubMed
Grevener K, Haveman LM, Ranft A, Management and outcome of Ewing sarcoma of the head and neck. Pediatr Blood Cancer 2016;63:604–610.)| false
• Search Google Scholar
• Export Citation

American Cancer Society. Survival rates for Ewing tumors. Accessed September 12, 2024. Available at: https://www.cancer.org/cancer/types/ewing-tumor/detection-diagnosis-staging/survival-rates.html

• PubMed
American Cancer Society. Survival rates for Ewing tumors. Accessed September 12, 2024. Available at: https://www.cancer.org/cancer/types/ewing-tumor/detection-diagnosis-staging/survival-rates.html)| false
• Search Google Scholar
• Export Citation

Bacci G, Boriani S, Balladelli A, et al. Treatment of nonmetastatic Ewing’s sarcoma family tumors of the spine and sacrum: the experience from a single institution. Eur Spine J 2009;18:1091–1095.

• PubMed
Bacci G, Boriani S, Balladelli A, Treatment of nonmetastatic Ewing’s sarcoma family tumors of the spine and sacrum: the experience from a single institution. Eur Spine J 2009;18:1091–1095.)| false
• Search Google Scholar
• Export Citation

Bosma SE, Ayu O, Fiocco M, et al. Prognostic factors for survival in Ewing sarcoma: a systematic review. Surg Oncol 2018;27:603–610.

• PubMed
Bosma SE, Ayu O, Fiocco M, Prognostic factors for survival in Ewing sarcoma: a systematic review. Surg Oncol 2018;27:603–610.)| false
• Search Google Scholar
• Export Citation

Cangir A, Vietti TJ, Gehan EA, et al. Ewing’s sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing’s sarcoma studies. Cancer 1990;66:887–893.

• PubMed
Cangir A, Vietti TJ, Gehan EA, Ewing’s sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing’s sarcoma studies. Cancer 1990;66:887–893.)| false
• Search Google Scholar
• Export Citation

Dang A, Feng X, Hamm J, et al. Survival outcomes in metastatic Ewing sarcoma treated with whole-lung radiation. Cureus 2022;14:e26750.

• PubMed
Dang A, Feng X, Hamm J, Survival outcomes in metastatic Ewing sarcoma treated with whole-lung radiation. Cureus 2022;14:e26750.)| false
• Search Google Scholar
• Export Citation

Paulino AC, Mai WY, Teh BS. Radiotherapy in metastatic ewing sarcoma. Am J Clin Oncol 2013;36:283–286.

• PubMed
Paulino AC, Mai WY, Teh BS. Radiotherapy in metastatic ewing sarcoma. Am J Clin Oncol 2013;36:283–286.)| false
• Search Google Scholar
• Export Citation

Oberlin O, Deley MC, Bui BN, et al. Prognostic factors in localized Ewing’s tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer 2001;85:1646–1654.

• PubMed
Oberlin O, Deley MC, Bui BN, Prognostic factors in localized Ewing’s tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer 2001;85:1646–1654.)| false
• Search Google Scholar
• Export Citation

Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone: final results of the cooperative Ewing’s Sarcoma Study CESS 86. J Clin Oncol 2001;19:1818–1829.

• PubMed
Paulussen M, Ahrens S, Dunst J, Localized Ewing tumor of bone: final results of the cooperative Ewing’s Sarcoma Study CESS 86. J Clin Oncol 2001;19:1818–1829.)| false
• Search Google Scholar
• Export Citation

Pan HY, Morani A, Wang WL, et al. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. Int J Radiat Oncol Biol Phys 2015;92:349–357.

• PubMed
Pan HY, Morani A, Wang WL, Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection. Int J Radiat Oncol Biol Phys 2015;92:349–357.)| false
• Search Google Scholar
• Export Citation

Kissane JM, Askin FB, Foulkes M, et al. Ewing’s sarcoma of bone: clinicopathologic aspects of 303 cases from the Intergroup Ewing’s Sarcoma Study. Hum Pathol 1983;14:773–779.

• PubMed
Kissane JM, Askin FB, Foulkes M, Ewing’s sarcoma of bone: clinicopathologic aspects of 303 cases from the Intergroup Ewing’s Sarcoma Study. Hum Pathol 1983;14:773–779.)| false
• Search Google Scholar
• Export Citation

Gupta AA, Pappo A, Saunders N, et al. Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer 2010;116:3189–3194.

• PubMed
Gupta AA, Pappo A, Saunders N, Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer 2010;116:3189–3194.)| false
• Search Google Scholar
• Export Citation

Lee J, Hoang BH, Ziogas A, Zell JA. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer 2010;116:1964–1973.

• PubMed
Lee J, Hoang BH, Ziogas A, Zell JA. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer 2010;116:1964–1973.)| false
• Search Google Scholar
• Export Citation

Treglia G, Salsano M, Stefanelli A, et al. Diagnostic accuracy of (1)(8)F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis. Skeletal Radiol 2012;41:249–256.

• PubMed
Treglia G, Salsano M, Stefanelli A, Diagnostic accuracy of (1)(8)F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis. Skeletal Radiol 2012;41:249–256.)| false
• Search Google Scholar
• Export Citation

Campbell KM, Shulman DS, Grier HE, DuBois SG. Role of bone marrow biopsy for staging new patients with Ewing sarcoma: a systematic review. Pediatr Blood Cancer 2021;68:e28807.

• PubMed
Campbell KM, Shulman DS, Grier HE, DuBois SG. Role of bone marrow biopsy for staging new patients with Ewing sarcoma: a systematic review. Pediatr Blood Cancer 2021;68:e28807.)| false
• Search Google Scholar
• Export Citation

Siegel MJ, Acharyya S, Hoffer FA, et al. Whole-body MR imaging for staging of malignant tumors in pediatric patients: results of the American College of Radiology Imaging Network 6660 Trial. Radiology 2013;266:599–609.

• PubMed
Siegel MJ, Acharyya S, Hoffer FA, Whole-body MR imaging for staging of malignant tumors in pediatric patients: results of the American College of Radiology Imaging Network 6660 Trial. Radiology 2013;266:599–609.)| false
• Search Google Scholar
• Export Citation

Boddu S, Walko CM, Bienasz S, et al. Clinical utility of genomic profiling in the treatment of advanced sarcomas: a single-center experience. JCO Precis Oncol 2018;2:1–8.

• PubMed
Boddu S, Walko CM, Bienasz S, Clinical utility of genomic profiling in the treatment of advanced sarcomas: a single-center experience. JCO Precis Oncol 2018;2:1–8.)| false
• Search Google Scholar
• Export Citation

Laetsch TW, Roy A, Xu L, et al. Undifferentiated sarcomas in children harbor clinically relevant oncogenic fusions and gene copy-number alterations: a report from the Children’s Oncology Group. Clin Cancer Res 2018;24:3888–3897.

• PubMed
Laetsch TW, Roy A, Xu L, Undifferentiated sarcomas in children harbor clinically relevant oncogenic fusions and gene copy-number alterations: a report from the Children’s Oncology Group. Clin Cancer Res 2018;24:3888–3897.)| false
• Search Google Scholar
• Export Citation

Avigad S, Cohen IJ, Zilberstein J, et al. The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer 2004;100:1053–1058.

• PubMed
Avigad S, Cohen IJ, Zilberstein J, The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer 2004;100:1053–1058.)| false
• Search Google Scholar
• Export Citation

de Alava E, Kawai A, Healey JH, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma. J Clin Oncol 1998;16:1248–1255.

• PubMed
de Alava E, Kawai A, Healey JH, EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma. J Clin Oncol 1998;16:1248–1255.)| false
• Search Google Scholar
• Export Citation

Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996;14:1245–1251.

• PubMed
Zoubek A, Dockhorn-Dworniczak B, Delattre O, Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996;14:1245–1251.)| false
• Search Google Scholar
• Export Citation

Le Deley MC, Delattre O, Schaefer KL, et al. Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol 2010;28:1982–1988.

• PubMed
Le Deley MC, Delattre O, Schaefer KL, Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol 2010;28:1982–1988.)| false
• Search Google Scholar
• Export Citation

van Doorninck JA, Ji L, Schaub B, et al. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children’s Oncology Group. J Clin Oncol 2010;28:1989–1994.

• PubMed
van Doorninck JA, Ji L, Schaub B, Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children’s Oncology Group. J Clin Oncol 2010;28:1989–1994.)| false
• Search Google Scholar
• Export Citation

Lambertini M, Del Mastro L, Pescio MC, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med 2016;14:1.

• PubMed
Lambertini M, Del Mastro L, Pescio MC, Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med 2016;14:1.)| false
• Search Google Scholar
• Export Citation

Practice Committee of the American Society for Reproductive Medicine. Electronic address aao. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril 2019;112:1022–1033.

• PubMed
Practice Committee of the American Society for Reproductive Medicine. Electronic address aao. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril 2019;112:1022–1033.)| false
• Search Google Scholar
• Export Citation

Burgert EO, Nesbit ME, Garnsey LA, et al. Multimodal therapy for the management of nonpelvic, localized Ewing’s sarcoma of bone: intergroup study IESS-II. J Clin Oncol 1990;8:1514–1524.

• PubMed
Burgert EO, Nesbit ME, Garnsey LA, Multimodal therapy for the management of nonpelvic, localized Ewing’s sarcoma of bone: intergroup study IESS-II. J Clin Oncol 1990;8:1514–1524.)| false
• Search Google Scholar
• Export Citation

Nesbit ME, Gehan EA, Burgert EO, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing’s sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 1990;8:1664–1674.

• PubMed
Nesbit ME, Gehan EA, Burgert EO, Multimodal therapy for the management of primary, nonmetastatic Ewing’s sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol 1990;8:1664–1674.)| false
• Search Google Scholar
• Export Citation

Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694–701.

• PubMed
Grier HE, Krailo MD, Tarbell NJ, Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694–701.)| false
• Search Google Scholar
• Export Citation

Shamberger RC, LaQuaglia MP, Gebhardt MC, et al. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 2003;238:563–567.

• PubMed
Shamberger RC, LaQuaglia MP, Gebhardt MC, Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 2003;238:563–567.)| false
• Search Google Scholar
• Export Citation

Krasin MJ, Davidoff AM, Rodriguez-Galindo C, et al. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors. Cancer 2005;104:367–373.

• PubMed
Krasin MJ, Davidoff AM, Rodriguez-Galindo C, Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors. Cancer 2005;104:367–373.)| false
• Search Google Scholar
• Export Citation

Wexler LH, DeLaney TF, Tsokos M, et al. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing’s sarcoma family of tumors. Cancer 1996;78:901–911.

• PubMed
Wexler LH, DeLaney TF, Tsokos M, Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing’s sarcoma family of tumors. Cancer 1996;78:901–911.)| false
• Search Google Scholar
• Export Citation

Rosito P, Mancini AF, Rondelli R, et al. Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience. Cancer 1999;86:421–428.